---
title: "Sagimet Biosciences Inc. (SGMT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SGMT.US.md"
symbol: "SGMT.US"
name: "Sagimet Biosciences Inc."
industry: "Biotechnology"
datetime: "2026-05-21T23:16:07.709Z"
locales:
  - [en](https://longbridge.com/en/quote/SGMT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SGMT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SGMT.US.md)
---

# Sagimet Biosciences Inc. (SGMT.US)

## Company Overview

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.sagimet.com](https://www.sagimet.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -9.44 | 443 | - | - | - |
| PB | 4.01 | 293 | 2.08 | 1.76 | 1.53 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T04:00:00.000Z

Total Analysts: **9**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 8 | 89% |
| Hold | 1 | 11% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 7.00 |
| Highest Target | 49.00 |
| Lowest Target | 8.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SGMT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SGMT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SGMT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SGMT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**